Utility of anakinra in Crimean Congo haemorrhagic fever with haemophagocyctic lymphohistiocytosis: a case report
- 10 June 2025
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 119 (10) , 1207-1210
Abstract
Crimean Congo haemorrhagic fever (CCHF) is an emerging, life-threatening tick-borne infection that can be fatal. As yet, there is no definitive treatment. In this case report we present a severe paediatric CCHF case that was successfully treated with anakinra. A previously healthy 13-year-old female presented with high fever, fatigue, rash and loss of appetite. Bone marrow aspiration showed rare haemophagocytocis and the patient's clinical condition continued to deteriorate. Anakinra was given on the day 5 of admission, as she was in the midst of cytokine storm syndrome. By the third day of anakinra, the patient's symptoms and laboratory tests improved. After 14 d of anakinra, she was discharged in full recovery. Anakinra may be a new therapeutic agent in CCHF, in which inflammation plays important role.Keywords
This publication has 11 references indexed in Scilit:
- Crimean-Congo Hemorrhagic Fever, Spain, 2013–2021Emerging Infectious Diseases, 2023
- Anakinra for the treatment of adult secondary HLH: a retrospective experienceInternational Journal of Hematology, 2022
- Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosisImmunologic Research, 2022
- Immunobiology of Crimean-Congo hemorrhagic feverAntiviral Research, 2022
- Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and EuropeMicroorganisms, 2021
- Current perspectives on the interleukin‐1 family as targets for inflammatory diseaseEuropean Journal of Immunology, 2019
- Cytokine response in crimean‐congo hemorrhagic fever virus infectionJournal of Medical Virology, 2017
- Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatalityInternational Journal of Infectious Diseases, 2008
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006
- C-reactive protein: a critical updateJournal of Clinical Investigation, 2003